期刊
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
卷 3, 期 7, 页码 552-555出版社
WILEY-BLACKWELL
DOI: 10.1002/acn3.314
关键词
-
We examined the clinical effectiveness of rituximab in fourteen patients with refractory myasthenia gravis ( MG). Manual muscle testing ( MMT) score was recorded at baseline and followed during the course of the study. Steroid dose, frequency of intravenous immunoglobulin ( IVIG) infusions, and plasma exchange ( PLEX) were also monitored throughout the duration of the study. All patients responded dramatically to rituximab, as measured by a change in MMT score, prednisone dose, or the frequency of IVIG infusions or PLEX. Rituximab appears safe and effective for the treatment of refractory MG. It should be considered as a therapeutic option in refractory patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据